EP. 1: Intro to Modifying the Course of Multiple Sclerosis: The Growing Treatment Armamentarium
EP. 2: Reduced Relapse Rates in Multiple Sclerosis
EP. 3: Nonresponse to Disease-modifying Therapies for Multiple Sclerosis
EP. 4: Applying Multiple Sclerosis Clinical Trial Outcomes to Practice
EP. 5: Mechanisms Behind New Multiple Sclerosis Medications
EP. 6: Antioxidative Pathways in Multiple Sclerosis
EP. 7: Risk Analysis of Natalizumab in Progressive Multifocal Leukoencephalopathy
EP. 8: Risk of Progressive Multifocal Leukoencephalopathy in Oral Therapies for Multiple Sclerosis
EP. 9: Balancing the Risks and Rewards of Multiple Sclerosis Medications
EP. 10: Achieving Adherence to Multiple Sclerosis Treatment
EP. 11: Looking at a Lack of Updated Guidelines
EP. 12: Who Should Treat Multiple Sclerosis Patients?
EP. 13: Meeting Patient Unmet Needs in Multiple Sclerosis Treatment
EP. 14: Closing Thoughts on Treatment Options
